Airò P - Search Results

1

Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years.

Bettoni L, Geri A, Airò P, Danieli E, Cavazzana I, Antonioli C, Chiesa L, Franceschini F, Grottolo A, Zambruni A, Radaeli E, Cattaneo R. Bettoni L, et al. Among authors: airo p. Clin Rheumatol. 2002 Jun;21(3):244-50. doi: 10.1007/pl00011223. Clin Rheumatol. 2002. PMID: 12111631

2

CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis.

Gorla R, Airò P, Malagoli A, Carella G, Prati E, Brugnoni D, Franceschini F, Cattaneo R. Gorla R, et al. Among authors: airo p. Clin Rheumatol. 1994 Mar;13(1):83-7. doi: 10.1007/BF02229871. Clin Rheumatol. 1994. PMID: 8187450

3

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results.

Airò P, Danieli E, Parrinello G, Antonioli CM, Cavazzana I, Toniati P, Franceschini F, Cattaneo R. Airò P, et al. Clin Exp Rheumatol. 2004 Sep-Oct;22(5):573-8. Clin Exp Rheumatol. 2004. PMID: 15485010

4

Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.

Airò P, Danieli E, Rossi M, Frassi M, Cavazzana I, Scarsi M, Grottolo A, Franceschini F, Zambruni A. Airò P, et al. Clin Exp Rheumatol. 2007 Mar-Apr;25(2):293-6. Clin Exp Rheumatol. 2007. PMID: 17543156 Clinical Trial.

5

Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group.

Airò P, Rossi M, Scarsi M, Danieli E, Grottolo A, Zambruni A. Airò P, et al. Clin Exp Rheumatol. 2007 Sep-Oct;25(5):722-7. Clin Exp Rheumatol. 2007. PMID: 18078620

6

[Long-term effects of cyclic therapy with iloprost in systemic sclerosis].

Scarsi M, Rossi M, Danieli E, Frigè A, Grottolo A, Zambruni A, Airò P. Scarsi M, et al. Among authors: airo p. Reumatismo. 2008 Apr-Jun;60(2):114-9. doi: 10.4081/reumatismo.2008.114. Reumatismo. 2008. PMID: 18651055 Free article. Italian.

7

Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus.

Airŏ P, Braga S, Prati E, Brugnoni D, Bettinzioli M, Gorla R, Cattaneo R. Airŏ P, et al. Clin Rheumatol. 1992 Mar;11(1):97-100. doi: 10.1007/BF02207093. Clin Rheumatol. 1992. PMID: 1582127

8

Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus.

Gorla R, Airò P, Franceschini F, Stefani E, Braga S, Tincani A, Cattaneo R. Gorla R, et al. Among authors: airo p. J Rheumatol. 1990 Aug;17(8):1048-53. J Rheumatol. 1990. PMID: 1698987

9

Clinical and serological features of 35 patients with anti-Ki autoantibodies.

Cavazzana I, Franceschini F, Vassalini C, Danieli E, Quinzanini M, Airò P, Cattaneo R. Cavazzana I, et al. Among authors: airo p. Lupus. 2005;14(10):837-41. doi: 10.1191/0961203305lu2226oa. Lupus. 2005. PMID: 16302679

10

Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitioners.

Airò P, Tabaglio E, Frassi M, Scarsi M, Danieli E, Rossi M. Airò P, et al. Clin Exp Rheumatol. 2007 Nov-Dec;25(6):878-80. Clin Exp Rheumatol. 2007. PMID: 18173923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters